These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7543739)

  • 1. [Magnetic resonance spectroscopy. A new technic for the study and the diagnosis of prostatic disease].
    García-Segura JM; Sánchez Chapado M
    Arch Esp Urol; 1995 Jun; 48(5):423-46. PubMed ID: 7543739
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostatic carcinoma and benign hypertrophy. Magnetic resonance aspects].
    Gevenois PA; Van Regemorter G; Van Sinoy ML; Diaz A; Struyven J
    Acta Urol Belg; 1986; 54(3):294-303. PubMed ID: 2430434
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic imaging in male pelvic disorders].
    Kaji Y; Sugimura K
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 May; 61(6):267-74. PubMed ID: 11431932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of NMR tomography in the diagnosis and staging of prostatic neoplasms].
    Beyer HK; Funke PJ; Brackins-Romero J; Uhlenbrock D
    Digitale Bilddiagn; 1986 Mar; 6(1):6-10. PubMed ID: 2421961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of the prostate.
    Poon PY; McCallum RW; Henkelman MM; Bronskill MJ; Sutcliffe SB; Jewett MA; Rider WD; Bruce AW
    Radiology; 1985 Jan; 154(1):143-9. PubMed ID: 2578070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma.
    Averna TA; Kline EE; Smith AY; Sillerud LO
    J Urol; 2005 Feb; 173(2):433-8. PubMed ID: 15643195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The abnormal prostate: MR imaging at 1.5 T with histopathologic correlation.
    Carrol CL; Sommer FG; McNeal JE; Stamey TA
    Radiology; 1987 May; 163(2):521-5. PubMed ID: 2436253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnetic resonance tomography in prostatic carcinoma and benign prostatic diseases with an endorectal and a new combined endorectal body phased-array coil].
    Engelhard K; Hollenbach HP; Ott G; Hausmann J; Risse W; Riedl C
    Rontgenpraxis; 1999; 52(7):214-23. PubMed ID: 10605323
    [No Abstract]   [Full Text] [Related]  

  • 9. Case study: Case No. 3. Supraprostatic nodule of benign prostatic hypertrophy and prostate carcinoma stage C.
    Gilbert TJ
    Semin Ultrasound CT MR; 1988 Oct; 9(5):377-8. PubMed ID: 2483528
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy.
    Cornel EB; Smits GA; Oosterhof GO; Karthaus HF; Deburyne FM; Schalken JA; Heerschap A
    J Urol; 1993 Dec; 150(6):2019-24. PubMed ID: 7693985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of tumor markers in the diagnosis of prostatic cancer].
    Casas Terrón E; Mari Ruiz M; Molina Andreu E
    Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Magnetic resonance imaging of pelvic tumors in men. Preliminary results in a series of 28 patients].
    Marichez M; Despres E; Duclos JM; Bourquelot P; Richard F; Parienty R; Brisset JM; Taieb A
    Ann Urol (Paris); 1986; 20(4):234-7. PubMed ID: 2427008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical use of endorectal coil MR in the study of prostatic pathology with special reference to hyperplasia and carcinoma].
    Gualdi GF; Polettini E; Casciani E
    Clin Ter; 1996; 147(1-2):51-66. PubMed ID: 8767956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign mimics of prostatic adenocarcinoma on needle biopsy.
    Gaudin PB; Reuter VE
    Anat Pathol; 1997; 2():111-34. PubMed ID: 9575372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum prostate-specific antigen (PSA) level diagnostic of prostate cancer.
    Yesner R; Kelly LJ; Chan YK
    Conn Med; 1996 Jul; 60(7):399-404. PubMed ID: 8758658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive angiomyxoma of the prostate mimicking benign prostatic hyperplasia.
    Bastian PJ; Fisang C; Schmidt ME; Biermann K; Textor J; Müller SC
    Eur J Med Res; 2006 Apr; 11(4):167-9. PubMed ID: 16720282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pelvic phlebography in the study of cancer of the prostate].
    Algranati R; Alberti C; Zingoni F
    Minerva Med; 1967 Nov; 58(95):4160-4. PubMed ID: 4170305
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications of radioactivity of prostatic secretion by means of P32 in prostatic diseases].
    Kaplun MI
    Med Radiol (Mosk); 1973 Oct; 18(10):58-60. PubMed ID: 4133507
    [No Abstract]   [Full Text] [Related]  

  • 19. Magnetic resonance imaging of the prostate.
    Schnall MD; Bezzi M; Pollack HM; Kressel HY
    Magn Reson Q; 1990 Jan; 6(1):1-16. PubMed ID: 1696493
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis of malignancy of prostate.
    Kapoor N; Surange S; Gupta KN; Husainy MA; Faizi M
    Indian J Pathol Microbiol; 2004 Apr; 47(2):186-8. PubMed ID: 16295464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.